Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunming CR Holy Fire Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in the modernization of Traditional Chinese Medicine (TCM). As a key subsidiary of China Resources Sanjiu Medical & Pharmaceutical, the company focuses on cardiovascular and cerebrovascular health, with its flagship product, Xuesaitong Soft Capsules (Panax Notoginseng Saponins), holding a significant market share in China. The company integrates research, cultivation of raw materials, and high-tech GMP manufacturing to produce purified herbal extracts. Its operations are centered in Kunming, Yunnan, leveraging the region's rich biodiversity for botanical sourcing and large-scale production of natural medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunming CR Holy Fire Pharmaceutical.